The protective effect of curcumin on myocardial ischemia-reperfusion injury

Korean Circulation Journal

Volumn 38, Issue 7, 2008, Pages 353-359

  Kim, Yong Sook ^a   Park, Hye Jeong ^a   Joo, Soo Yeon ^a   Hong, Moon Hwa ^a   Kim, Kye Hun ^a   Hong, Young Joon ^a   Kim, Ju Han ^a   Park, Hyung Wook ^a   Jeong, Myung Ho ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Ahn, Youngkeun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Apoptosis; Curcumin; Inflammation; Ischemia reperfusion injury

Indexed keywords

CURCUMIN; DNA NUCLEOTIDYLEXOTRANSFERASE; MALONALDEHYDE; MYELOPEROXIDASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERY LIGATION; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NEUTROPHIL; NICK END LABELING; NONHUMAN; RAT; REPERFUSION INJURY; TREATMENT DURATION;

EID: 51349144036     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.7.353     Document Type: Article

References (30)

1. Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 2002;17:114-9.
2. Brown JM, Anderson BO, Repine JE, et al. Neutrophils contribute to TNF induced myocardial tolerance to ischaemia. J Mol Cell Cardiol 1992;24:485-95.
3. Nakamura M, Wang NP, Zhao ZQ, et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000;45:661-70.
4. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
5. Cook-Mills JM. VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol 2002;39:499-508.
6. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005;41:1955-68.
7. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
8. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995; 206:533-40.
9. Kang G, Kong PJ, Yuh YJ, et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 2004;94:325-8.
10. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94:79-83.
11. Lin JK. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch Pharm Res 2004;27:683-92.
12. Liu X, Xie W, Liu P, et al. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci 2006;78:2255-64.
13. Nitobe J, Yamaguchi S, Okuyama M, et al. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res 2003;57:119-28.
14. Leclercq IA, Farrell GC, Sempoux C, dela Pena A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 2004;41:926-34.
15. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kapp B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286:G367-76.
16. Kim YS, Jhon DY, Lee KY. Involvement of ROS and JNK1 in selenite-induced apoptosis in Chang liver cells. Exp Mol Med 2004;36:157-64.
17. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-12.
18. Georas SN, Liu MC, Newman W, Beall LD, Stealey BA, Bochner BS. Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. Am J Respir Cell Mol Biol 1992;7:261-9.
19. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269-75.
20. Hagar H, Ueda N, Shah SV. Tyrosine phosphorylation in DNA damage and cell death in hypoxic injury to LLC-PK1 cells. Kidney Int 1997;51:1747-53.
21. Kim YS, Ahn Y, Hong MH, et al. Curcumin attenuates nuclear factor-kapp B, c-Jun N-terminal kinase and p 38 in tumor necrosis factor-alpha-stimulated human endothelial cells. Korean Circ J 2006;36:482-9.
22. Ahn Y, Kim YS, Jeong MH. The role of nuclear factor kappa B activation in atherosclerosis and ischemic cardiac injury. Korean Circ J 2006;36:245-51.
23. Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian J Exp Biol 1980;18 73-5.
24. Qureshi S, Shah AH, Aged AM. Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med 1992;58:124-7.
25. Lao CD, Demierre MF, Sondak VK. Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Rev Anticancer Ther 2006;6:1559-68.
26. Lao CD, Ruffin MT 4th, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006; 6:10.
27. Howells LM, Moiseeva EP, Neal CP, et al. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 2007;28:1274-304.
28. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999; 27:486-94.
29. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004;74:969-85.
30. Liu A, Lou H, Zhao L, Fan P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 2006;40:720-7.